Corn protein is reported to have 70-90 percent protein and a high level of branch chain amino acids. Zeins are the most abundant protein in corn, accounting about 44-79 percent of total protein. Corn protein market is predicted to increase at a substantial rate during the anticipated period, owing to increased demand for natural and plant-based goods. The number of 'gluten avoiders switching to gluten-free diets for a better lifestyle out of choice rather than need is rising. Consumers' growing understanding and awareness of gluten-free foods and food intolerance has resulted in a rise in demand for vegan or plant-based goods like maize protein. Corn protein has been related to a number of health advantages, including a reduced risk of stroke, cancer, and heart disease mortality. In comparison to animal protein, corn protein contains necessary amino acids. Saturated fat and dietary cholesterol are abundant in animal protein, which raises the risk of heart disease. Corn protein is a healthful, meat-free product that meets the protein needs of vegan customers.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
High demand for maize protein in the medical business due to its lack of virulence and risk compared to animal protein, as well as rising disposable incomes, are expected to increase demand for maize protein in the projection period. Furthermore, with the growing trend of veganism, customers' preferences are shifting toward plant-based goods, even in historically meat-eating countries like the United States and Europe.
In 2018, a large maize protein maker commissioned an online poll of 1,923 grocery stores in the United States that had purchased plant protein in the previous months, and more than half of the respondents agreed to attempt to include more plant-based protein in their diets.
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT